Literature DB >> 9457056

Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines.

E Costanzi-Strauss1, B E Strauss, R K Naviaux, M Haas.   

Abstract

The aim of this study was to demonstrate that the induction of growth arrest in human glioblastoma multiforme (GBM) cell lines by retrovirus-mediated transduction of growth control genes was dependent upon the integrity of specific endogenous control pathways. We assessed the status of the endogenous p16INK4A, p21CIP1, pRb, or p53 genes in eight GBM lines. As expected, we found varied combinations of gene defects. The outcome of transducing five of these cell lines with p16INK4A, p21CIP1, pRb, or p53 genes was not entirely predictable. The growth-inhibitory effects mediated by the transfer of the gene encoding p16 was dependent on the presence of the pRb protein, but was independent of p53 status. p21, a broadly active CDK inhibitor and a strong inducer of growth arrest, was not a universal growth suppressor in the group of glioblastoma cell lines analyzed. The suppression of GBM cell proliferation by viruses encoding pRb or p53 was generally predictable and appeared to be independent of the status of either p16 or p21. Suppression of cell growth was assessed by a colony formation assay, by observance of alterations in morphology, and by cell viability staining for trypan blue exclusion. Our findings suggest that to accomplish the suppression of GBM cell proliferation by the transduction of these cell-cycle control genes, the status of endogenous cell-cycle control genes must be taken into account.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9457056     DOI: 10.1006/excr.1997.3810

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Inhibition of T-cell acute lymphoblastic leukemia proliferation in vivo by re-expression of the p16INK4a tumor suppressor gene.

Authors:  K Schoppmeyer; P S Norris; M Haas
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

2.  Widdrol activates DNA damage checkpoint through the signaling Chk2-p53-Cdc25A-p21-MCM4 pathway in HT29 cells.

Authors:  Hee Jung Yun; Sook Kyung Hyun; Jung Ha Park; Byung Woo Kim; Hyun Ju Kwon
Journal:  Mol Cell Biochem       Date:  2011-12-11       Impact factor: 3.396

3.  Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression.

Authors:  Matthias Simon; Christian Simon; Gertraud Köster; Volkmar H J Hans; Johannes Schramm
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

Review 4.  The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth.

Authors:  S M Ivanchuk; S Mondal; P B Dirks; J T Rutka
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.

Authors:  Rodrigo Esaki Tamura; Rafael Bento da Silva Soares; Eugenia Costanzi-Strauss; Bryan E Strauss
Journal:  Cancer Biol Ther       Date:  2016-09-19       Impact factor: 4.742

6.  Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence.

Authors:  A Tsugu; K Sakai; P B Dirks; S Jung; R Weksberg; Y L Fei; S Mondal; S Ivanchuk; C Ackerley; P A Hamel; J T Rutka
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

7.  Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas.

Authors:  Muhamad Thohar Arifin; Seiji Hama; Yoshinori Kajiwara; Kazuhiko Sugiyama; Taiichi Saito; Shinya Matsuura; Fumiyuki Yamasaki; Kazunori Arita; Kaoru Kurisu
Journal:  J Neurooncol       Date:  2006-04-14       Impact factor: 4.130

8.  Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo.

Authors:  Juliana G Xande; Ana P Dias; Rodrigo E Tamura; Mario C Cruz; Bárbara Brito; Robledo A Ferreira; Bryan E Strauss; Eugenia Costanzi-Strauss
Journal:  Gene Ther       Date:  2019-08-22       Impact factor: 5.250

9.  HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs.

Authors:  Carolyn Culver; Andrew Melvin; Sharon Mudie; Sonia Rocha
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

10.  Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.

Authors:  Eva Gömöri; József Pál; Bernadett Kovács; Tamás Dóczi
Journal:  Diagn Pathol       Date:  2012-01-20       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.